Osteoporosis research breakthrough 'could lead to earlier diagnosis'RSS Feed

A significant research breakthrough could improve the treatment of the spinal injury caused by osteoporosis.

Research published in journal Cell Metabolism identified a new gene that modulates bone mass, and is potentially a risk factor for developing osteoporosis.

The study's objective was to understand the molecular and cellular mechanisms that determine the balance between bone formation and breakdown.

Scientists studied the role of new gene that influences osteoclasts, which reshape the bone, and osteoblasts, which are responsible for making bones.

It was found that a loss of this gene's function in mice led to a significant increase in the number of osteoclasts.

Study leader Dr Jean Vacher commented: "The human gene could represent a new susceptibility factor for osteoporosis. Hence, this discovery will help identify individuals with a greater predisposition to the disease who could benefit from preventive measures."

This follows University of Rochester research which revealed that an osteoporosis medication could be used to treat arthritis, as it works by building cartilage around joints.

News by Serious Law. Expert legal assistance for those affected by spinal injury

Posted by Matthew Heap
 

Common supplement 'could help walking ability after spinal cord injury'

29 September 2011

A commonly used supplement could improve outcomes and recovery from spinal cord injury, scientists have said.University of Kentucky researchers found that the supplement acetyl-L-carnitine (ALC) could...

Read More...

Scientists find out more about spinal injury in spinal muscular atrophy

27 September 2011

Researchers have gained a new insight into the spinal injury seen in spinal muscular atrophy.A team from the University of Missouri identified the communication breakdown between nerves and muscles in...

Read More...

German man undergoes first neural stem cell trial for spinal injury

23 September 2011

Neural stem cells have been transplanted into a spinal cord injury patient in the first trial of its kind.The procedure, at Netwark's StemCells Inc, was carried out on Wednesday (September 21st), and...

Read More...